NEW DELHI (Reuters) – India’s drug regulator on Friday approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, two sources with knowledge of the matter told Reuters.
A representative of India’s Central Drugs Standard Control Organization (CDSCO), whose experts were meeting for the second time this week, declined to comment.
(Reporting by Krishna N. Das and Nigam Prusty; Editing by Gareth Jones)
Oh baby! Emma and Liam are the top New York City baby names once again
Manhattan DA says ‘Neighborhood Navigator’ program has helped more than 700 people get essential aid, including housing and mental health
QC New York expands with 15,000-square-foot Building 111 on Governors Island
Op-ed: Fentanyl is killing thousands – it’s time to stop it
amNewYork’s 2024 Year in Review: Ranking the top 24 New York athletes of the year
A look ahead: What does 2025 hold for interest rates, inflation?
Juan Soto sets record straight on Yankees’ treatment of family
Mikal Bridges easing any concerns that he won’t fit with Knicks
Sixers celebrate Christmas with 118-114 win over Celtics in Boston
Fire breaks out at Bryant Park Winter Village, marking second holiday market blaze in two weeks
amNY Year in Review | A look at the top 10 web stories of 2024
Advocates hold prayer vigil in Brooklyn for woman burned alive on F train, demand officials stem violence on subways
Israeli Consul General Ofir Akunis talks war in Gaza, antisemitism during visit to Philadelphia
History Column: Preserving historic train stations in Philadelphia
